Ardent Health Partners, LLC (NYSE:ARDT) Receives $20.67 Average Price Target from Analysts

Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) has earned a consensus recommendation of "Buy" from the thirteen research firms that are presently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, nine have given a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $20.67.

A number of research firms have commented on ARDT. Guggenheim upped their price target on Ardent Health Partners from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Friday, May 9th. Mizuho decreased their price objective on shares of Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $21.00 target price on shares of Ardent Health Partners in a report on Thursday, May 15th. Finally, Stephens reissued an "overweight" rating and set a $21.00 price target on shares of Ardent Health Partners in a report on Tuesday, May 20th.

Institutional Investors Weigh In On Ardent Health Partners

Several institutional investors and hedge funds have recently added to or reduced their stakes in ARDT. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Ardent Health Partners during the 4th quarter valued at approximately $27,000. US Bancorp DE purchased a new position in Ardent Health Partners during the 4th quarter worth $31,000. Morse Asset Management Inc purchased a new position in Ardent Health Partners in the first quarter worth $36,000. New York State Common Retirement Fund acquired a new stake in shares of Ardent Health Partners during the 4th quarter valued at approximately $48,000. Finally, Deutsche Bank AG lifted its holdings in shares of Ardent Health Partners by 1,251.9% in the fourth quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock valued at $49,000 after purchasing an additional 2,654 shares in the last quarter.

Ardent Health Partners Stock Down 8.3%

Shares of NYSE:ARDT traded down $1.23 during midday trading on Friday, hitting $13.63. 447,007 shares of the company's stock were exchanged, compared to its average volume of 386,174. Ardent Health Partners has a 12 month low of $11.31 and a 12 month high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The company has a market cap of $1.95 billion and a PE ratio of 8.36. The stock has a 50 day moving average price of $13.50 and a 200-day moving average price of $14.57.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.08. The firm had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.50 billion. On average, sell-side analysts anticipate that Ardent Health Partners will post 1.23 EPS for the current fiscal year.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.